|
[posting]33407136[/posting]Founder auch in der Pharmasparte tätig _____________________________________________________________________ In the recent years, Founder Group has entered into Pharmaceutical Industry through investment, merger and acquisition, and other methods as well. Currently, Pharmaceutical Industry has been promoted to one of the main industry in Founder Group. Relying on Peking University, Founder Group integrates various resources in the companies, and establishes a strategy of internationalization. At preset, Founder Group holds three companies in its pharmaceutical industry — Southwest Synthetic Pharmaceutical Co., Ltd., Chongqing Daxin Pharmaceutical Co., Ltd. and Yantai Zhongzhou Pharmaceutical Co., Ltd. Business activities involve production, distribution, R&D of APIs (Active Pharmaceutical Ingredients), Finished dosage, and Chinese Traditional Medicine. Southwest Synthetic Pharmaceutical Co., Ltd. is the most important pharmaceutical APIs manufacturer in southwest China. It is mainly engaged in R&D, manufacturing and marketing for bulk pharmaceuticals and finished dosages. This company produces more than 10 categories, 47 varieties of bulk pharmaceuticals and 41 kinds of finished dosages, such as antibiotics, analgesics, vitamins, anti-infections, psychotropic drug and etc. At present, there are 6 injection products, 2 pieces of small capacity injection in the company; 10 bulk pharmaceuticals have been provided with GMP certificates from SFDA, 4 APIs have been approved by U.S. FDA, and 4 APIs have CEP/COS from EDQM. Its products enjoy high reputation abroad. Products Catalogue of Southwest Synthetic (http://www.sspgf.com/english/Products.htm) Chongqing Daxin Pharmaceutical Co., Ltd. was established in 1941, mainly engaged in the operation of APIs and finished dosages, which include human drugs and veterinary drugs. The company has been assessed as Key National Biochemical Pharmaceutical Enterprise and National class II Multiple Pharmaceutical Enterprise. This company had been appraised as the Best 50 Industrial Enterprises in Chongqing, and it is also a big taxpayer there. Chongqing Daxin has four APIs approved by U.S. FDA, and one product be provide with CEP/COS from EDQM. The quality of their products has reached the international advanced level that greatly welcomed by domestic and overseas clients. Products Catalogue of Chongqing Daxin (http://www.cqdxyy.com/web/top3-1e.asp) Yantai Zhongzhou Pharmaceutical Co., Ltd. is a modern enterprise engaged in R&D, production and marketing for Chinese Traditional Medicines. Its products include 6 types and 2 formulations including Xin An Ning tablet, Xue Ning Capsule and YinQiao antidotal tablet. The newly developed medicine —Tuoluo Yinxie Capsule, is a Class I national new drug specially for psoriasis disease. Contact Us Add: 12th Floor, Kangde Building, No.34 Hongjin Road, Longxi Town, Yubei District, Chongqing, China Postcode: 401147 Tel: 86-23-67518055 Fax: 86-23-67519202 Email:gaiming@188.com Founder Worldwide: Peking University | Contact Us | Site Map Copyright (C) 2004. Founder Group All rights reserved. E-mail:contact@founder.com |
|
| aus der Diskussion: | Weis jemand warum Founder wieder steigt??? |
| Autor (Datum des Eintrages): | quickclick (19.02.08 23:25:51) |
| Beitrag: | 138 von 224 (ID:33418102) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |